# US 2023/0056888 A1 · Compositions comprising cyanidin-3-galactoside for use as vasorelaxant

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0056888 A1
- Document ID: US20230056888A1
- Status: Published application
- Kind: A1
- Application number: 17/787,254
- Filed: 2020-12-16
- Published: 2023-02-23
- Earliest claimed: 2019-12-19
- Assignees: Evonik Operations GmbH
- Applicants: Evonik Operations GmbH
- Inventors: Rosario LIZIO; Michael SCHWARM; Albino CARRIZZO; Carmine VECCHIONE
- Web page: https://patentgrep.com/patent/US20230056888A1

## CPC

- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61K 36/45: Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
- A61K 36/5775: {Hibiscus}
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/08: Vasodilators for multiple indications
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/51: Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A composition may be used in vascular relaxation, wherein the composition may include one or more anthocyanins.

## Claims

### Claim 1

A composition suitable for use in vascular relaxation, the composition comprising:
cyanidin-3-galactoside having a formula:
(b) cyanidin-3-rutinoside (b-i), delphinidin-3-arabinoside (b-ii), and delphinidin-3-sambubioside (b-iii).

### Claim 2 (depends on 1)

The composition of claim 1, further comprising:
a fruit or fruit extract.

### Claim 3 (depends on 1)

The composition of claim 1, comprising:
bilberry, sweet cherry, and cowberry/lingonberry, optionally as extract(s).

### Claim 4 (depends on 1)

The composition of claim 1, comprising:
an extract of black currant and bilberry.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the black currant is from Ribes nigrum and/or the bilberry is from Vaccinium myrtillus.

### Claim 6 (depends on 1)

The composition of claim 1, comprising anthocyanins at a concentration of at least 25 wt. %.

### Claim 7 (depends on 2)

The composition of claim 2, wherein the extract is present and is an alcoholic extract, preferably a methanol extract.

### Claim 8 (depends on 2)

The composition of claim 2, wherein the extract is present and is prepared by a process comprising:
extracting a black currant and/or bilberry, to obtain an extract;
purifying the extract via chromatography, to obtain a purified extract;
mixing the purified extract(s) with water, to obtain a mixture; and
spray-drying the mixture.

### Claim 9 (depends on 1)

A method for preventing or treating a cardiovascular disease or disorder, the method comprising:
providing a subject in need thereof with the composition of claim 1, thereby prevent or treating the disease or disorder.

### Claim 10

A composition, comprising:
black currant, (black) chokeberry, bilberry, and sweet cherry, optionally as extract(s),
wherein the composition comprises anthocyanins and the anthocyanins are present in the composition in a concentration of at least 5 μg/mL.

### Claim 11 (depends on 10)

The composition of claim 10, further comprising:
cowberry, lingonberry, hibiscus, or elderberry, optionally as extract(s).

### Claim 12 (depends on 10)

The composition of claim 10, comprising:
the black currant, (black) chokeberry, bilberry, and sweet cherry or extract in a weight ratio in a range of from 0.5 to 5:0.25 to 2.5:15 to 35:50 to 70.

### Claim 13 (depends on 12)

The composition of claim 12, comprising:
the black currant, (black) chokeberry, bilberry, and sweet cherry in a weight ratio of around 1:0.4:25:60.

### Claim 14 (depends on 1)

The composition of claim 1, further comprising:
bilberry, black currant, and/or black chokeberry, optionally as extract(s).

### Claim 15 (depends on 1)

The composition of claim 1, further comprising:
cowberry/lingonberry and bilberry, optionally as extract(s).

### Claim 16 (depends on 1)

The composition of claim 1, further comprising:
black scented rice; and
sweet cherry or black currant or red currant,
optionally as extract(s).

### Claim 17 (depends on 4)

The composition of claim 4, comprising the extract from the black currant and the bilberry in a weight ratio in a range of from 0.5:1 to 1:0.5.

### Claim 18 (depends on 2)

The composition of claim 2, wherein the extract is present and is a methanol extract.

### Claim 19 (depends on 1)

A method for preventing or treating a atherosclerosis, hypertension, stroke, diabetes-related cardiovascular disfunctions, ischemia/reperfusion injury, hypercholesterolemia, coronary artery disease, or chronic obstructive pulmonary disease, the method comprising:
providing a subject in need thereof with the composition of claim 1, thereby preventing or treating the atherosclerosis, hypertension, stroke, diabetes-related cardiovascular disfunctions, ischemia/reperfusion injury, hypercholesterolemia, coronary artery disease, or chronic obstructive pulmonary disease.
